Final Clinical Outcomes from a Phase 2 Trial of Posoleucel, an Off-the-Shelf, Multivirus-Specific T-Cell Therapy, for the Prevention of Clinically Significant Viral Infections Post-HCT
Autor: | Sanjeet S Dadwal, Jo-Anne H. Young, Michael W. Schuster, Jean A. Yared, Gary Douglas Myers, Michelle Matzko, Sama Adnan, Joshua A. Hill, Rajat Bansal |
---|---|
Rok vydání: | 2022 |
Předmět: | |
Zdroj: | Blood. 140:878-879 |
ISSN: | 1528-0020 0006-4971 |
DOI: | 10.1182/blood-2022-169122 |
Databáze: | OpenAIRE |
Externí odkaz: |